We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Thrombotargets Corporation Launches  BioPlatformScreen™  Service
Product News

Thrombotargets Corporation Launches BioPlatformScreen™ Service

Thrombotargets Corporation Launches  BioPlatformScreen™  Service
Product News

Thrombotargets Corporation Launches BioPlatformScreen™ Service


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Thrombotargets Corporation Launches BioPlatformScreen™ Service"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Thrombotargets has developed and adapted to high throughput screening named BioPlatformScreen™ that change completely the concept of HTS Service.

According to Company, these new family of biological assays are capable to quantify simultaneously clot formation and clot lysis (Hemosta-BioplatformScreen™), total antioxidant capacity (Oxidant-BioplatformScreen™) and low-density lipoprotein modification (Athero-BioplatformScreen™).

Advertisement